Advertisement

Index by author

June 01, 1986; Volume 29,Issue 6

A

  1. Alvarez, R

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

  2. Anundi, I M

    1. Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;

  3. Armstrong, R D

    1. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;

B

  1. Bachur, N R

    1. DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;

  2. Banerjee, G L

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

  3. Bolger, M B

    1. Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;

  4. Boyd, N D

    1. Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;

  5. Brown, R D

    1. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;

  6. Bruno, J J

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

C

  1. Cadman, E C

    1. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;

  2. Cain, C

    1. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;

  3. Cantoni, O

    1. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;

  4. Conn, P M

    1. Hormone-stimulated redistribution of gonadotrope protein kinase C in vivo: dependence on Ca2+ influx.
      C A McArdle and P M Conn
      Molecular Pharmacology June 1986, 29 (6) 570-576;

  5. Costa, M

    1. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;

D

  1. Dolnick, B J

    1. 5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells.
      C L Will and B J Dolnick
      Molecular Pharmacology June 1986, 29 (6) 643-648;

E

  1. el-Mouelhi, M

    1. Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;

H

  1. Hagiwara, M

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  2. Hidaka, H

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  3. Hughes, R J

    1. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
      R J Hughes and P A Insel
      Molecular Pharmacology June 1986, 29 (6) 521-530;

I

  1. Inagaki, M

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  2. Insel, P A

    1. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
      R J Hughes and P A Insel
      Molecular Pharmacology June 1986, 29 (6) 521-530;

  3. Iracki, T

    1. DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;

  4. Itoh, H

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

J

  1. Jones, G L

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

K

  1. Kamaya, H

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

  2. Kaminoh, Y

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

  3. Kauffman, F C

    1. Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;

  4. Kawamoto, S

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  5. Keys, C

    1. Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

  6. Kuczenski, R

    1. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
      K A Strait and R Kuczenski
      Molecular Pharmacology June 1986, 29 (6) 561-569;

L

  1. Larsson, A

    1. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;

  2. Lin, S H

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

  3. Linthicum, D S

    1. Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;

  4. Littschwager, K

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

  5. Loew, G

    1. Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

  6. Lueddens, H W

    1. AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

  7. Luke, B

    1. Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

M

  1. Ma, S M

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

  2. Maynard, A T

    1. An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;

  3. McArdle, C A

    1. Hormone-stimulated redistribution of gonadotrope protein kinase C in vivo: dependence on Ca2+ influx.
      C A McArdle and P M Conn
      Molecular Pharmacology June 1986, 29 (6) 570-576;

  4. McKinney, J D

    1. An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;

N

  1. Newman, A H

    1. AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

O

  1. Oblas, B

    1. Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;

P

  1. Pan, S S

    1. DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;

  2. Parnerud, A M

    1. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;

  3. Patierno, S R

    1. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;

  4. Pedersen, L G

    1. An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;

  5. Polgar, W

    1. Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

  6. Posner, H S

    1. An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;

  7. Prendiville, P

    1. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;

R

  1. Rice, K C

    1. AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

S

  1. Saitoh, M

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  2. Sherman, M A

    1. Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;

  3. Singer, R H

    1. Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;

  4. Skolnick, P

    1. AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

  5. Strait, K A

    1. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
      K A Strait and R Kuczenski
      Molecular Pharmacology June 1986, 29 (6) 561-569;

  6. Strosberg, A M

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

  7. Sugiyama, M

    1. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;

  8. Sundqvist, A

    1. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;

T

  1. Takahashi, J

    1. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

  2. Takimoto, C H

    1. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;

  3. Thurman, R G

    1. Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;

  4. Toll, L

    1. Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

  5. Tseng, H S

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

U

  1. Ueda, I

    1. Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

V

  1. Venuti, M C

    1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

W

  1. Will, C L

    1. 5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells.
      C L Will and B J Dolnick
      Molecular Pharmacology June 1986, 29 (6) 643-648;
Back to top

In this issue

Advertisement